Literature DB >> 26486342

Bubble-Assisted Ultrasound: Application in Immunotherapy and Vaccination.

Jean-Michel Escoffre1, Roel Deckers2, Clemens Bos3, Chrit Moonen2.   

Abstract

Bubble-assisted ultrasound is a versatile technology with great potential in immunotherapy and vaccination. This technology involves the exposure of immune cells (i.e., dendritic cells, lymphocytes) in-vitro or diseased tissues (i.e., brain, tumor) in-vivo to ultrasound treatment with gas bubbles. Bubble destruction leads to physical forces that induce the direct delivery of weakly permeant immuno-stimulatory molecules either into the cytoplasm of immune cells, or through the endothelial barrier of diseased tissues. Hence, therapeutic antibodies (i.e., antibody-based immunotherapy) and cytokine-encoding nucleic acids (i.e., cytokine gene therapy) can be successfully delivered into diseased tissues, thus improving immune responses. In addition, protein antigens, as well as antigen-encoding nucleic acids (pDNA, mRNA), can be delivered into dendritic cells (i.e., dendritic cell-based vaccines), thus leading to a long-lasting prophylactic or therapeutic immunization. This chapter focuses on the state-of-the-art of bubble-assisted ultrasound in the field of immunotherapy and vaccination.

Entities:  

Keywords:  Bubble; Immunotherapy; Ultrasound; Vaccination

Mesh:

Year:  2016        PMID: 26486342     DOI: 10.1007/978-3-319-22536-4_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma.

Authors:  Yun Liu; Jinjun Jiang; Chaoqi Liu; Wensi Zhao; Yao Ma; Zhiwei Zheng; Qing Zhou; Yun Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.

Authors:  Monica Argenziano; Sergio Occhipinti; Anna Scomparin; Costanza Angelini; Francesco Novelli; Marco Soster; Mirella Giovarelli; Roberta Cavalli
Journal:  Drug Deliv Transl Res       Date:  2022-06-07       Impact factor: 5.671

Review 3.  Ultrasound-guided drug delivery in cancer.

Authors:  Sayan Mullick Chowdhury; Taehwa Lee; Jürgen K Willmann
Journal:  Ultrasonography       Date:  2017-05-01

4.  Ultrasonically and Iontophoretically Enhanced Drug-Delivery System Based on Dissolving Microneedle Patches.

Authors:  Moonjeong Bok; Zhi-Jun Zhao; Sohee Jeon; Jun-Ho Jeong; Eunju Lim
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

5.  Artificial intelligence and guidance of medicine in the bubble.

Authors:  Asma Akbar; Nagavalli Pillalamarri; Sriya Jonnakuti; Mujib Ullah
Journal:  Cell Biosci       Date:  2021-06-09       Impact factor: 7.133

Review 6.  The crosstalk between sonodynamic therapy and autophagy in cancer.

Authors:  Yujie Zhang; Yuanru Zhao; Yuanyuan Zhang; Qingguang Liu; Mingzhen Zhang; Kangsheng Tu
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

7.  Cavitation-threshold Determination and Rheological-parameters Estimation of Albumin-stabilized Nanobubbles.

Authors:  Maxime Lafond; Akiko Watanabe; Shin Yoshizawa; Shin-Ichiro Umemura; Katsuro Tachibana
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

Review 8.  Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy.

Authors:  Jiawei Tu; Hui Zhang; Jinsui Yu; Chun Liufu; Zhiyi Chen
Journal:  Onco Targets Ther       Date:  2018-09-12       Impact factor: 4.147

Review 9.  Ultrasound-Responsive Materials for Drug/Gene Delivery.

Authors:  Xiaowen Cai; Yuan Jiang; Mei Lin; Jiyong Zhang; Huanhuan Guo; Fanwen Yang; Wingnang Leung; Chuanshan Xu
Journal:  Front Pharmacol       Date:  2020-01-31       Impact factor: 5.810

Review 10.  Mechanistic Insights and Therapeutic Delivery through Micro/Nanobubble-Assisted Ultrasound.

Authors:  Shirui Lu; Pengxuan Zhao; Youbin Deng; Yani Liu
Journal:  Pharmaceutics       Date:  2022-02-22       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.